Dominique Ibañez

Dominique Ibañez

UNVERIFIED PROFILE

Are you Dominique Ibañez?   Register this Author

Register author
Dominique Ibañez

Dominique Ibañez

Publications by authors named "Dominique Ibañez"

Are you Dominique Ibañez?   Register this Author

50Publications

952Reads

38Profile Views

Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus.

J Rheumatol 2016 05 15;43(5):875-9. Epub 2016 Feb 15.

From the University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.M.B. Urowitz, MD, FRCPC, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; D. Ibañez, MSc, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; J. Su, MB, BSc University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; D.D. Gladman, MD, FRCPC, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150983DOI Listing
May 2016

Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.

J Rheumatol 2015 Dec 15;42(12):2318-26. Epub 2015 Nov 15.

From the University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network; Division of Rheumatology, Department of Medicine, and Department of Immunology, University of Toronto; Arthritis Centre of Excellence, Division of Health Care and Outcomes Research, Toronto Western Hospital Research Institute, University Health Network; Arthritis Centre of Excellence, Division of Genetics and Development, Toronto Western Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.A.J. Steiman, MD, MSc, FRCP, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, and Division of Rheumatology, Department of Medicine, University of Toronto; D.D. Gladman, MD, FRCP, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, and Division of Rheumatology, Department of Medicine, University of Toronto, and Arthritis Centre of Excellence, Division of Health Care and Outcomes Research, Toronto Western Hospital Research Institute, University Health Network; D. Ibañez, MSc, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network; B. Noamani, MSc, Arthritis Centre of Excellence, Division of Genetics and Development, Toronto Western Hospital Research Institute, University Health Network; C. Landolt-Marticorena, MD, PhD, FRCP, Division of Rheumatology, Department of Medicine, University of Toronto; M.B. Urowitz, MD, FRCP, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, and Division of Rheumatology, Department of Medicine, University of Toronto, and Arthritis Centre of Excellence, Division of Health Care and Outcomes Research, Toronto Wes

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150040DOI Listing
December 2015

SLEDAI-2K Does Not Conceal Worsening in a Particular System When There Is Overall Improvement.

J Rheumatol 2015 Aug 15;42(8):1401-5. Epub 2015 Jun 15.

From the University of Toronto, University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, and Toronto Western Research Institute, Toronto, Ontario, Canada.Z. Touma, MD, FACP, FACR, PhD, Assistant Professor of Medicine, University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, and Senior Scientist, Toronto Western Research Institute, and Co-director, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto; J. Su, MB, BSc; D. Ibañez, MSc, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; M.B. Urowitz, MD, FRCPC, Professor of Medicine, University of Toronto, and Senior Scientist, Toronto Western Research Institute, and Director, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141088DOI Listing
August 2015

Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.

J Rheumatol 2015 May 1;42(5):810-6. Epub 2015 Mar 1.

From the University of Toronto; Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital; Toronto Western Hospital; Arthritis Centre of Excellence, Division of Genetics and Development, Toronto Western Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.A.J. Steiman, MD, FRCPC, Rheumatology Fellow, University of Toronto, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; M.B. Urowitz, MD, FRCPC, Professor of Medicine, University of Toronto, and Director, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; D. Ibañez, MSc, Biostatistician, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; T.T. Li, MSc, Medical Student, Arthritis Centre of Excellence, Division of Genetics and Development, Western Hospital Research Institute, University Health Network; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, and Deputy Director, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; J. Wither, MD, PhD, FRCPC, Professor of Medicine, University of Toronto, Arthritis Centre of Excellence, Division of Genetics and Development, Toronto Western Hospital Research Institute, University Health Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140796DOI Listing
May 2015

Isolated hematuria and sterile pyuria may indicate systemic lupus erythematosus activity.

J Rheumatol 2015 Mar 15;42(3):437-40. Epub 2015 Jan 15.

From the University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.Jonathan Y.C. Ding was the recipient of the Canadian Rheumatology Association Roche Summer Studentship.J.Y.C. Ding, BSc, Medical Student, University of Toronto; D. Ibañez, MSc, Biostatistician, Centre for Prognosis Studies in the Rheumatic Diseases; D.D. Gladman, MD, FRCPC, Professor of Medicine, Senior Scientist, University of Toronto; M.B. Urowitz, MD, FRCPC, Professor of Medicine, Senior Scientist, University of Toronto.

View Article

Download full-text PDF

Source
http://www.jrheum.org/cgi/doi/10.3899/jrheum.140415
Publisher Site
http://dx.doi.org/10.3899/jrheum.140415DOI Listing
March 2015

Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes.

Arthritis Care Res (Hoboken) 2014 Dec;66(12):1905-9

University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.22364DOI Listing
December 2014

Prolonged clinical remission in patients with systemic lupus erythematosus.

J Rheumatol 2014 Sep 1;41(9):1808-16. Epub 2014 Aug 1.

From the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; University of Toronto, Toronto, Ontario, Canada.A.J. Steiman, MD, FRCPC, Rheumatology Fellow; M.B. Urowitz, MD, FRCPC, Professor of Medicine, Director; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, and the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; D. Ibañez, MSc, Biostatistician, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; A. Papneja, Medical Student, Toronto Western Hospital Research Institute, University Health Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.131137DOI Listing
September 2014

American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort.

J Rheumatol 2014 May 1;41(5):875-80. Epub 2014 Apr 1.

From the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada; Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Department of Rheumatology, Hospital for Rheumatic Diseases and Hanyang University Medical Center, Seoul, Korea; Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Montreal General Hospital and McGill University Health Centre, Montreal, Quebec, Canada; Centre Hospitalier Universitaire de Québec et Université Laval, Quebec City, Quebec, Canada; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada; Centre for Rheumatology Research, University College, London, UK; Cedars-Sinai/David Geffen School of Medicine, University of California, Los Angeles, California, USA; Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York, USA; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA; Department of Rheumatology, University Hospital Lund, Lund, Sweden; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama, USA; Center for Rheumatology Research, Landspitali University Hospital, Reyjkavik, Iceland; Northwestern University and Feinber

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130704DOI Listing
May 2014

Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment.

J Rheumatol 2014 Apr 15;41(4):688-97. Epub 2014 Jan 15.

From the University of Toronto Lupus Clinic, Toronto Western Hospital, Centre for Prognosis Studies in the Rheumatic Diseases, and the Toronto Western Research Institute, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.130005
Publisher Site
http://dx.doi.org/10.3899/jrheum.130005DOI Listing
April 2014

Assessment of coronary risk based on cumulative exposure to lipids in systemic lupus erythematosus.

J Rheumatol 2013 Dec 15;40(12):2006-14. Epub 2013 Oct 15.

From the University of Toronto Lupus Clinic and the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto, Ontario, Canada; The University of Melbourne Departments of Medicine and Rheumatology, St. Vincent's Hospital, Melbourne, Victoria, Australia; Division of Cardiology, Women's College Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.121273DOI Listing
December 2013

Recommendations for frequency of visits to monitor systemic lupus erythematosus in asymptomatic patients: data from an observational cohort study.

J Rheumatol 2013 May 1;40(5):630-3. Epub 2013 Mar 1.

University of Toronto Lupus Clinic and the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.121094DOI Listing
May 2013

Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity.

Clin Biochem 2013 Mar 12;46(4-5):317-20. Epub 2012 Dec 12.

Department of Clinical Biochemistry, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00099120120069
Publisher Site
http://dx.doi.org/10.1016/j.clinbiochem.2012.12.004DOI Listing
March 2013

Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study.

Arthritis Res Ther 2011 29;13(5):R156. Epub 2011 Sep 29.

University of Toronto Lupus Clinic and the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/ar3473DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308087PMC
December 2012

Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months.

Rheumatology (Oxford) 2012 Oct 19;51(10):1814-9. Epub 2012 Jun 19.

Department of Medicine, Division of Rheumatology, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
https://academic.oup.com/rheumatology/article-lookup/doi/10.
Publisher Site
http://dx.doi.org/10.1093/rheumatology/kes146DOI Listing
October 2012

High-sensitivity C-reactive protein as a marker of cardiovascular risk in systemic lupus erythematosus.

Arthritis Rheum 2012 Sep;64(9):3052-3

Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.34541DOI Listing
September 2012

Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.

Arthritis Care Res (Hoboken) 2012 Jun 30;64(6):833-7. Epub 2012 Jan 30.

Centre for Prognosis Studies in Rheumatic Diseases and Toronto Western Hospital, 399 Bathurst Street, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.21624DOI Listing
June 2012

Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period.

Arthritis Care Res (Hoboken) 2012 Apr;64(4):511-8

University of Toronto Lupus Clinic and Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.21568DOI Listing
April 2012

Ability of non-fasting and fasting triglycerides to predict coronary artery disease in lupus patients.

Rheumatology (Oxford) 2012 Mar 24;51(3):528-34. Epub 2011 Nov 24.

Toronto Western Hospital, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/ker339DOI Listing
March 2012

Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.

J Rheumatol 2011 Nov 1;38(11):2395-9. Epub 2011 Sep 1.

University of Toronto Lupus Clinic, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.110550DOI Listing
November 2011

Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus.

Arthritis Care Res (Hoboken) 2011 Nov;63(11):1517-20

University of Toronto Lupus Clinic and Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.20599DOI Listing
November 2011

Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?

J Rheumatol 2011 Sep 1;38(9):1898-905. Epub 2011 Jul 1.

Centre for Prognosis Studies in the Rheumatic Diseases, Room 1E-409, Toronto Western Hospital, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.110007DOI Listing
September 2011

Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50.

J Rheumatol 2011 Feb 1;38(2):275-84. Epub 2010 Dec 1.

Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Room 1E-409, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.100724DOI Listing
February 2011

Optimal frequency of visits for patients with systemic lupus erythematosus to measure disease activity over time.

J Rheumatol 2011 Jan 15;38(1):60-3. Epub 2010 Nov 15.

University of Toronto Lupus Clinic and Centre for Prognosis Studies in the Diseases, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.100575DOI Listing
January 2011

Variability over time and correlates of cholesterol and blood pressure in systemic lupus erythematosus: a longitudinal cohort study.

Arthritis Res Ther 2010 30;12(3):R125. Epub 2010 Jun 30.

University of Toronto Lupus Clinic and the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/ar3063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911919PMC
November 2010

Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome.

J Rheumatol 2010 Sep 1;37(9):1822-7. Epub 2010 Jul 1.

University of Toronto, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.100007DOI Listing
September 2010

The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications.

J Rheumatol 2010 Apr 15;37(4):754-8. Epub 2010 Mar 15.

University of Toronto Lupus Clinic, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.090872DOI Listing
April 2010

Risk factors for development of coronary artery disease in women with systemic lupus erythematosus.

J Rheumatol 2009 Nov 15;36(11):2454-61. Epub 2009 Oct 15.

University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Division of Rheumatology, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.090011DOI Listing
November 2009

Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus.

Arthritis Rheum 2009 Sep;61(9):1152-8

University of Toronto Lupus Clinic and the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.24741DOI Listing
September 2009

Myocardial perfusion imaging in assessing risk of coronary events in patients with systemic lupus erythematosus.

J Rheumatol 2009 Feb 22;36(2):288-94. Epub 2009 Jan 22.

University of Toronto Lupus Clinic and the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.080776DOI Listing
February 2009

Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus.

J Rheumatol 2008 Nov 15;35(11):2152-8. Epub 2008 Sep 15.

Toronto Western Hospital, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Canada.

View Article

Download full-text PDF

Source
November 2008

Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.

Arthritis Rheum 2008 Feb;58(2):556-62

Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.23204DOI Listing
February 2008

Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide.

J Rheumatol 2007 Jul 15;34(7):1491-6. Epub 2007 Jun 15.

University of Toronto Lupus Clinic, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
July 2007

Summarizing disease features over time: II. Variability measures of SLEDAI-2K.

J Rheumatol 2007 Feb 15;34(2):336-40. Epub 2006 Dec 15.

Centre for Prognostic Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
February 2007

Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors.

J Rheumatol 2007 Jan 15;34(1):70-5. Epub 2006 Nov 15.

University of Toronto Lupus Clinic, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
January 2007

Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression.

J Rheumatol 2006 Dec;33(12):2453-7

University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
December 2006

The effect of menopause on disease activity in systemic lupus erythematosus.

J Rheumatol 2006 Nov 15;33(11):2192-8. Epub 2006 Sep 15.

University of Toronto Lupus Clinic and Toronto Western Hospital, Edith Cavell Wing, 399 Bathurst Street, Toronto, Ontario, M5T 2S8, Canada.

View Article

Download full-text PDF

Source
November 2006

Ethnic variation in disease patterns and health outcomes in systemic lupus erythematosus.

J Rheumatol 2006 Oct 15;33(10):1990-5. Epub 2006 Aug 15.

Division of Rheumatology, Centre for Prognostic Studies in the Rheumatic Diseases, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
October 2006

Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent.

J Rheumatol 2006 Sep 15;33(9):1785-8. Epub 2006 Aug 15.

Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
September 2006

Prolonged remission in systemic lupus erythematosus.

J Rheumatol 2005 Aug;32(8):1467-72

University of Toronto Lupus Clinic, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, University Health Network, Ontario, Canada.

View Article

Download full-text PDF

Source
August 2005

Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus.

Arthritis Rheum 2005 Aug;53(4):609-12

Toronto Western Hospital, University Health Network Research Institute, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.21314DOI Listing
August 2005

Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE.

J Rheumatol 2005 May;32(5):824-7

Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
May 2005

The effect of pregnancy on lupus nephritis.

Arthritis Rheum 2004 Dec;50(12):3941-6

Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.20638DOI Listing
December 2004

Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study.

Arthritis Rheum 2003 Nov;48(11):3159-67

University of Toronto Lupus Clinic, and Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.11296DOI Listing
November 2003

Accrual of organ damage over time in patients with systemic lupus erythematosus.

J Rheumatol 2003 Sep;30(9):1955-9

University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst Street, EC 5-034, Toronto, Ontario, Canada M5T 2S8.

View Article

Download full-text PDF

Source
September 2003

Clinically active serologically quiescent systemic lupus erythematosus.

J Rheumatol 2003 Sep;30(9):1960-2

University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst Street, EC 5-034, Toronto, Ontario, Canada M5T 2S8.

View Article

Download full-text PDF

Source
September 2003

Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus.

J Rheumatol 2003 Sep;30(9):1977-82

University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst Street, EC 5-034, Toronto, Ontario, Canada M5T 2S8.

View Article

Download full-text PDF

Source
September 2003

Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities.

J Rheumatol 2003 Feb;30(2):288-91

University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
February 2003

Systemic lupus erythematosus disease activity index 2000.

J Rheumatol 2002 Feb;29(2):288-91

The University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.jrheum.org/content/29/2/288.full.pdf
Web Search
February 2002